AU2013365769B2 - Antimicrobial compounds, their synthesis and applications thereof - Google Patents

Antimicrobial compounds, their synthesis and applications thereof Download PDF

Info

Publication number
AU2013365769B2
AU2013365769B2 AU2013365769A AU2013365769A AU2013365769B2 AU 2013365769 B2 AU2013365769 B2 AU 2013365769B2 AU 2013365769 A AU2013365769 A AU 2013365769A AU 2013365769 A AU2013365769 A AU 2013365769A AU 2013365769 B2 AU2013365769 B2 AU 2013365769B2
Authority
AU
Australia
Prior art keywords
lys
boc
group
compound
str
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013365769A
Other languages
English (en)
Other versions
AU2013365769A1 (en
Inventor
Padma AKKAPEDDI
Chandradhish GHOSH
Jayanta Haldar
Goutham Belagula MANJUNATH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Department of Health and Social Care
Jawaharlal Nehru Centre for Advanced Scientific Research
Original Assignee
Sec Dep For Health
Department of Health and Social Care
Jawaharlal Nehru Centre for Advanced Scientific Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sec Dep For Health, Department of Health and Social Care, Jawaharlal Nehru Centre for Advanced Scientific Research filed Critical Sec Dep For Health
Publication of AU2013365769A1 publication Critical patent/AU2013365769A1/en
Application granted granted Critical
Publication of AU2013365769B2 publication Critical patent/AU2013365769B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2013365769A 2012-12-18 2013-12-18 Antimicrobial compounds, their synthesis and applications thereof Ceased AU2013365769B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN5299CH2012 2012-12-18
IN5299/CHE/2012 2012-12-18
PCT/IB2013/061090 WO2014097178A1 (en) 2012-12-18 2013-12-18 Antimicrobial compounds, their synthesis and applications thereof

Publications (2)

Publication Number Publication Date
AU2013365769A1 AU2013365769A1 (en) 2015-07-02
AU2013365769B2 true AU2013365769B2 (en) 2018-03-15

Family

ID=54148251

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013365769A Ceased AU2013365769B2 (en) 2012-12-18 2013-12-18 Antimicrobial compounds, their synthesis and applications thereof

Country Status (9)

Country Link
US (1) US9783490B2 (cg-RX-API-DMAC7.html)
EP (1) EP2934563B1 (cg-RX-API-DMAC7.html)
JP (1) JP6533466B2 (cg-RX-API-DMAC7.html)
CN (1) CN104981249B (cg-RX-API-DMAC7.html)
AU (1) AU2013365769B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015014391B1 (cg-RX-API-DMAC7.html)
CA (1) CA2894202A1 (cg-RX-API-DMAC7.html)
HK (1) HK1210437A1 (cg-RX-API-DMAC7.html)
WO (1) WO2014097178A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105566149B (zh) * 2016-03-02 2017-05-24 郑州大学 具有抗菌活性的查尔酮阳离子抗菌肽模拟物及其制备方法
CN106995384B (zh) * 2017-04-21 2018-12-11 郑州大学 具有抗菌活性的二烷基阳离子两亲性抗菌肽模拟物及其制备方法
CN120118207A (zh) 2017-12-15 2025-06-10 丹娜-法伯癌症研究院有限公司 稳定肽-介导的靶向蛋白降解

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017888A1 (en) * 1993-12-30 1995-07-06 Smithkline Beecham Corporation Phenylmethyl hexanamides, and the use thereof
WO2007129952A1 (en) * 2006-05-09 2007-11-15 Neobiotics Ab Novel peptide derivatives useful as antimicrobial agents for treating wounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07501085A (ja) 1992-09-03 1995-02-02 ベーリンガー インゲルハイム コマンディトゲゼルシャフト 新規なアミノ酸誘導体、その製造方法及びこれらの化合物を含む医薬組成物
US5654451B1 (en) * 1993-01-14 2000-02-22 Magainin Pharma Amino acids and peptides having modified c-terminals and modified n-terminals
US5663148A (en) 1994-07-12 1997-09-02 Abbott Laboratories Anaphylatoxin receptor ligands containing lipophilic residues
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
AU697565B2 (en) 1995-12-12 1998-10-08 Taiho Pharmaceutical Co., Ltd. Epoxysuccinamide derivative or salt thereof and medicine comprising the same
CA2217550A1 (en) * 1996-10-22 1998-04-22 F. Hoffmann-La Roche Ag Cationic lipids for gene therapy
RU2200154C2 (ru) * 1997-12-12 2003-03-10 Дайичи Файн Кемикал Ко., Лтд. Новые ингибиторы металлопротеиназ
AU2180201A (en) * 1999-11-30 2001-06-12 Aventis Pharma S.A. Hydroxamic acid macrocyclic derivatives, preparation method and compositions containing same
JP2002161084A (ja) * 2000-11-28 2002-06-04 Sumitomo Pharmaceut Co Ltd 複素環誘導体
US7393836B2 (en) 2004-07-06 2008-07-01 Boehringer Ingelheim International Gmbh D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
GB0512751D0 (en) * 2005-06-22 2005-07-27 Glaxo Group Ltd New adjuvant
US20080118525A1 (en) * 2006-10-04 2008-05-22 Oreola Donini Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
JP2010512417A (ja) * 2006-12-11 2010-04-22 ワイス エルエルシー イオンチャネルモジュレータ−
CN102757477B (zh) * 2011-04-27 2014-09-03 首都医科大学 烯丙基半胱氨酰氨基酸甲酯衍生物及其合成方法和应用
DK2709619T3 (en) * 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017888A1 (en) * 1993-12-30 1995-07-06 Smithkline Beecham Corporation Phenylmethyl hexanamides, and the use thereof
WO2007129952A1 (en) * 2006-05-09 2007-11-15 Neobiotics Ab Novel peptide derivatives useful as antimicrobial agents for treating wounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SVENSON JOHAN ET AL, JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 50, no. 14, doi:10.1021/JM0703542, ISSN 0022-2623, (2007-07-12), pages 3334 - 3339, (2007-06-15) *

Also Published As

Publication number Publication date
CA2894202A1 (en) 2014-06-26
JP2016504330A (ja) 2016-02-12
WO2014097178A1 (en) 2014-06-26
BR112015014391A2 (pt) 2017-07-11
EP2934563A4 (en) 2016-08-17
US20150329478A1 (en) 2015-11-19
HK1210437A1 (en) 2016-04-22
US9783490B2 (en) 2017-10-10
CN104981249B (zh) 2018-06-19
EP2934563A1 (en) 2015-10-28
BR112015014391B1 (pt) 2020-11-03
EP2934563B1 (en) 2020-07-08
JP6533466B2 (ja) 2019-06-19
CN104981249A (zh) 2015-10-14
AU2013365769A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
US11325955B2 (en) Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
EP2350116B1 (en) Treatment of biofilms
JP5524858B2 (ja) 抗菌性化合物
CN104284664A (zh) 广谱抗生素Arylomycin类似物
KR20120104986A (ko) 의료용 펩티드
US20200071361A1 (en) Engineered antimicrobial amphiphilic peptides and methods of use
CN103209700A (zh) 广谱抗生素Arylomycin类似物
WO1998022493A2 (en) N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
US8541365B2 (en) Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof
AU2015279705A1 (en) Acinetobacter lysins
EP3765057A1 (en) Treatment of implants with engineered antimicrobial amphiphilic peptides
KR20170052613A (ko) 효모/곰팡이에 의해 유발되는 감염을 치료하기 위한 시스테아민의 사용
EP2934563B1 (en) Antimicrobial compounds, their synthesis and applications thereof
WO2022173981A1 (en) Intravenous administration of engineered antimicrobial amphiphilic peptides
CN108078982A (zh) 脯氨酸衍生物在制备β-内酰胺酶抑制剂中的用途
CN106083994A (zh) 取代的噁唑烷酮水溶性衍生物及其应用
WO2020196315A1 (ja) 細胞層透過促進剤、薬剤吸収補助用組成物、及び医薬組成物
Hachim et al. Design, molecular docking, synthesis, and antimicrobial evaluation of new dipeptide derivatives of ceftizoxime sodium
Behroz Structure-activity relationship studies of albicidin’s C-terminal dipeptide and N-terminal cinnamoyl residue
WO2025240758A1 (en) Staphylococcus hominis daptide antibiotics, derivatives thereof, and methods of treatment
JP2009502810A (ja) 補体系と相互作用する抗微生物剤
EP3335720A1 (en) C-di-gmp binding peptides
Class et al. Patent application title: DENDRIMERIC PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME Inventors: Neville R. Kallenbach (Philadelpha, PA, US) Filbert Totsingan (Brooklyn, NY, US)
CN108084075A (zh) 具有β-内酰胺酶抑制作用的脯氨酸衍生物

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired